Altria is reportedly in "advanced talks" to acquire #3 U.S. e-cigarette maker NJOY for $2.75bn. We see this as the wrong decision. NJOY is a distant #3 in U.S. Vapor. Precedents elsewhere suggest it ...

Altria bought NJOY and plugged the company's vaping product into its distribution network. NJOY is enjoying a huge boost in sales, leading to enthusiasm among investors. There are good things ...

The agency is still reviewing applications for two menthol-flavored NJOY Daily e-cigarettes. See if you qualify for a free subscription to our industry leading paper magazine.

The FDA recently authorized the sale of four menthol-flavored NJOY products from Altria. NJOY could help the company return to revenue growth. The stock is inexpensive with a robust dividend that is ...

Plans call for increasing awareness and appeal among adult smokers and adult vapers through NJOY ACE expansion. Get news highlights delivered directly to your e-mail inbox.

The Food and Drug Administration’s first-ever authorization of menthol-flavored electronic cigarette devices may be a game-changer for public health for smokers trying to quit traditional cigarettes, ...

Altria Group’s (NYSE:MO) reported interest in NJOY is not good news for investors, according to Bernstein analyst Callum Elliott. Elliott explained that while the interest on Altria’s part is ...

Adult smokers are looking for alternatives and NJOY offers a multitude of products across three e-vapor categories. Officials at NJOY have a pretty specific mission: to make traditional cigarettes ...